EurekAlert! -
1 May 2017 06:00
(New York Genome Center) Dr. Sanjana's three-year grant was awarded for his research entitled "A human T cell genetic screen for melanoma immunotherapy," which aims to characterize genetic mutations that lead to immunotherapy resistance in melanoma.
Share this Article